Elena Vasti (@ecvasti) profile picture

Internal Medicine @stanforddeptmed via @ucsfmedicine and @UCLAFSPH. Heart failure/valve disease/public health researcher/implementation science/disparities

Palo Alto, California
Joined April 2018
Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)Photo by Elena Vasti (@ecvasti)
Thank you @MasriAhmadMD for visiting Stanford for @StanfordDeptMed Cardiology Grand Rounds. Superb state-of-the-art talk on the state of HCM. Next time don’t bring the Portland weather with you! ☂️ 🌧️ @joshuawknowles @StanCVFellows @ecvasti @EldrinL @ChadSWeldy @Paul_P_Cheng @euanashley
2
6
34
3,245
New blog: Fresh dueling guidelines about post-arrest care from the AHA & ESICM 💔 BP & O2 targets 💔 Who needs emergent cath? 💔 pan-CT scans 💔 temp targets 💔 neuroprognostication Which guideline do I love? 😍 You'll have to read the post to see emcrit.org/pulmcrit/2025-arr…
6
101
5
372
38,809
Incredible Stanford Cardiology Grand Rounds by @David_Ouyang on AI in Cardiology. He’s a true pioneer of the field & we’re so proud he is a @StanfordMedRes & @StanCVFellows alum. And look at all those @StanfordMedRes #friendsoftheprogram alumni he’s collaborating with! 🙂 @LongNguyen07 @AndrewPAmbrosy @ATSandhu @Paul_P_Cheng @StanfordDeptMed
2
10
3
78
12,301
🔥 New in @NatureMedicine How do you communicate lifetime benefits expected with HFpEF therapies? New data from 3 RCTs (#DELIVER #FINEARTS #PARAGON) estimate up to *5 years* of event-free survival w combination Rx #GDMT for HFpEF has finally arrived! 🔗nature.com/articles/s41591-0…
8
140
6
342
38,012
Retrospective analysis of patients with #HFrEF with ICD, #GLP1RA use was associated with significant ⤴️in heart rate & ⤴️ number of nonsustained ventricular events and total shock/antitachycardia pacing therapies @JACCJournals
2
16
4
72
45,310
Novel Devices for #HFpEF 🔥 #ELEVATEHFpEF Personalized Pacing #CASTLEHFpEF AF Ablation #AIMHigher Cardiac Contractility Modulator #RESPONDERHF #ALLAY Interatrial Shunt #REBALANCE Splanchnic Nerve Ablation #ALLEVIATEHF Insertable Monitor Watch this space! jacc.org/doi/10.1016/j.jchf.…
Press release @medtronic on our pivotal #ELEVATE-HFpEF RCT which will test the efficacy & safety of a personalized elevated pacing rate (based on LVEF & height) in #HFpEF 75 countries 2 patients enrolled already (AUS & US) Methods to be presented @HFSA news.medtronic.com/2025-09-1…
2
23
1
51
7,679
Congrats to #StanDOM's @ATSandhu & Jason Hom! With collaborators from @aboutKP, @CedarsSinai & @MassGenBrigham, they secured a $5 million @American_Heart grant to advance #AI in #CardiovascularCare for better screening & treatment! k-p.li/4oyy2e5
3
2
13
3,329
#Dronedarone exhibited significantly lower rates of CV hospitalization & VAs compared w/ #sotalol. These findings provide real-world evidence to support selection of the most appropriate first-line AAD for rhythm control in pts w/ #AFib. jacc.org/doi/10.1016/j.jacep… #JACCCEP
2
34
2
137
15,071
South Asian individuals have greater CVD event rates and comprise 1 in 4 individuals worldwide. However, in our systematic review of 310 major CVD trials led by @NishantUppal7, only 3% of trial participants are South Asian individuals sciencedirect.com/science/ar… @JACCJournals #JACCAsia @AniruddhPatelMD @DLBHATTMD
5
38
6
153
30,247
Heart Failure With Improved Ejection Fraction: Definitions, Epidemiology, and Management HFimpEF remains relatively understudied, and uncertainty persists regarding its long-term prognosis and optimal management jacc.org/doi/abs/10.1016/j.j…
2
43
88
8,241
Distinguishing athlete’s heart from #cardiomyopathy? 🫀 ✅ GLS & RV strain usually preserved in athletes ⚠️ ⬇️GLS or RV strain = 🚩 for HCM/ARVC 🧠 LA strain, morphologic/TDI + #CMR can help 📎: jacc.org/doi/10.1016/j.jcmg.… #ACCAthleticHeart #EchoFirst #JACCIMG #SportsCardio #cvHCM
2
49
1
145
13,488
#StanDOM's HEARs program is growing! Congrats to 2025 grads: Emily Li-wen Chu, Megan Yoko Galan, Sophie Lee Gough, Hoda Elisabeth Sayegh, Maria Theresa Hanna, Sunil K. Joshi, Rebecca Lewinsohn & Wilson Lay Tang! stanford.io/4kl9piF
2
6
1,393
Patients with heart failure and HFimpEF remain at high risk for cardiovascular events, but finerenone consistently reduces this risk without significant adverse effects. ja.ma/4jjmY0T @orlyvardeny @mvaduganathan @HFpEF @AdriaanVoors @clara_clarais
1
17
1
47
5,571
Replying to @Stanford_HF
8
20
2,026
1-month #DAPT duration was associated w/ similar total NACE & MACCE & reduced total 🩸 risk compared w/ prolonged DAPT. Findings support the use of an abbreviated duration of DAPT after #PCI in high 🩸 risk patients. jacc.org/doi/10.1016/j.jacc.… #EuroPCR #JACC @vlgmrc @dariobongio
20
2
52
6,631
Excited to share a @UCSFHospitals and @CedarsSinai collaboration recently published in @accpchest. How I do it: Best practices for right heart catheterization in the diagnosis of pulmonary hypertension - CHEST journal.chestnet.org/article…
6
23
965
Elena Vasti retweeted
Honored to be part of the first event! Thank you @NanditaScottMD @sarma_amy @GarimaVSharmaMD for hosting us. @MGHWomenHeart What an incredible experience: History and science! Enjoyed meeting everyone and learning from their work 🫀
Introducing the first cohort of @ISHVnews and @MGHWomenHeart Young Investigator Awards Finalists in Women's CVH! What amazing things you will accomplish! @GoRedForWomen @AHAScience @ACCinTouch
2
14
686
Cannot think of a more deserving person for this award - Beyond lucky to learn from my “HF clinic dad” Dr. Sallam!
We're proud to announce that #StanDOM's Karim Sallam has been named the 2025 recipient of the Alwin C. Rambar – James B.D. Mark Award for Excellence in Patient Care. His compassion, dedication & teamwork define excellence at @StanfordMed. Congratulations, Karim!
1
170